by Waltteri Sorvisto | Oct 2, 2025 | Commerzialisation
Germany is one of Europe’s largest healthcare markets, but successfully bringing a medical device to German patients requires more than MDR certification. To be competitive, manufacturers must also consider reimbursement pathways early in their market strategy....
by Waltteri Sorvisto | Sep 25, 2025 | Medical Device Services
In the world of medical devices under EU MDR (EU 2017/745), the clinical evaluation process is a cornerstone of demonstrating safety and performance. At its heart are two interlinked documents: the Clinical Evaluation Plan (CEP) – which defines how you’ll gather...
by Waltteri Sorvisto | Sep 18, 2025 | Medical Device Services
Biological safety remains a critical part of bringing a medical device to market under EU MDR (EU 2017/745). Two documents in particular matter: the Biological Evaluation Plan (BEP), which lays the groundwork for identifying and managing biological risks; and the...
by Waltteri Sorvisto | Sep 11, 2025 | FDA, Medical Device Services
For many medical device companies, the United States is not only one of the largest healthcare markets in the world—it’s also a gateway to global opportunities. FDA clearance or approval is widely recognized as a gold standard in medical device regulation, and...
by Waltteri Sorvisto | Sep 4, 2025 | FDA, Medical Device Services
When bringing a medical device to market, one of the most important strategic choices manufacturers face is deciding whether to pursue approval in the United States under the FDA or in the European Union under the EU-MDR. Both frameworks are globally respected, but...
